Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy.
about
The significance of cagA(+) Helicobacter pylori in reflux oesophagitisComparison of four serological tests to determine the CagA or VacA status of Helicobacter pylori strains.New immunological assays for the diagnosis of Helicobacter pylori infection.How should Helicobacter pylori positive dyspeptic patients be managed?Prevalence of CagA and VacA antibodies in children with Helicobacter pylori-associated peptic ulcer compared to prevalence in pediatric patients with active or nonactive chronic gastritis.Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal modelsAccuracy of a commercial enzyme-linked immunosorbent assay for CagA in patients from Brazil with and without gastric carcinoma.Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsiaRisk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study.Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish populationPepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity.Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island.
P2860
Q28346251-033A53B4-6332-4FDA-9C06-027175E62386Q33688630-0BE5EE13-684E-4383-9AAB-E73568E76ACBQ33717339-26315B5B-F4CB-4B22-8E82-E6104E80BE2AQ33717345-BD32C40D-6DC0-492F-8832-736F0C096C3FQ33998672-C8B57AF9-706F-4207-BC84-60B13161CBD3Q34007173-E69CEA9F-9292-4991-A134-0293AFECAFAAQ34747017-18119A9C-5047-4CAB-B166-8E21019E7B8BQ35398387-DB81619C-F549-4968-BB71-5BE0D3869B8FQ35594635-CCBF67C7-ABA2-45CD-8CC7-651A66A76A52Q36190752-EFA0127E-EACF-44AD-B325-0BA5203E41BCQ37355104-6AB8134C-F24E-43AB-B317-D00230A0CE60Q42716553-6FDD54F4-6416-4B72-AC3E-721118A1EF19Q43087274-35B815FE-B18E-43F2-9827-EF8658FA9175
P2860
Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Usefulness of anti-Helicobacte ...... n of patients for gastroscopy.
@ast
Usefulness of anti-Helicobacte ...... n of patients for gastroscopy.
@en
type
label
Usefulness of anti-Helicobacte ...... n of patients for gastroscopy.
@ast
Usefulness of anti-Helicobacte ...... n of patients for gastroscopy.
@en
prefLabel
Usefulness of anti-Helicobacte ...... n of patients for gastroscopy.
@ast
Usefulness of anti-Helicobacte ...... n of patients for gastroscopy.
@en
P2093
P1476
Usefulness of anti-Helicobacte ...... on of patients for gastroscopy
@en
P2093
Heikkinen M
Janatuinen E
Julkunen R
Pikkarainen P
P304
P407
P577
1997-12-01T00:00:00Z